CLA

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1626

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 10 of 1,626 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2022-001686-12-BE (EUCTR)	13/02/2023	05/12/2022	Long-term Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulc ...	A Phase 2 Long-Term Extension (LTE) Study to Evaluate The Safety and Efficacy of Efavaleukin Alfa in ...	Moderate to Severe Active Ulcerative Colitis (UC) MedDRA version: 20.1;Level: LLT;Classification cod ...	Product Name: Efavaleukin Alfa Product Code: AMG 592 INN or Proposed INN: Efavaleukin alfa	Amgen Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 2	Russian Federation;United States;Czechia;Greece;Austria;Netherlands;Korea, Republic of;Poland;Bulgar ...
2	EUCTR2022-002593-89-CZ (EUCTR)	23/01/2023	28/12/2022	A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Cr ...	A 24-Week, Phase 2b, Randomized, Double-Blind Long-Term Extension Study to Evaluate Pharmacokinetics ...	Moderate to severe Ulcerative colitis or moderate to severe Crohn'sdisease MedDRA version: 20.1;Leve ...	Product Name: TEV-48574 Product Code: TEV-48574 INN or Proposed INN: TEV-48574 Other descriptive name: ...	Teva Branded Pharmaceutical Products R&D, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	128	Phase 2	United States;Czechia;Slovakia;Spain;Austria;Israel;United Kingdom;Italy;France;Hungary;Czech Republ ...
3	EUCTR2021-006881-19-CZ (EUCTR)	06/01/2023	06/01/2023	A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn’s Disease	A 14-Week Phase 2b, RandomizEd, Double-BLind, Dose-Ranging Study to Determine the PharmacokInetics, ...	Moderate to severe Ulcerative colitis or moderate to severe Crohn's disease MedDRA version: 20.1;Lev ...	Product Name: TEV-48574 Product Code: TEV-48574 INN or Proposed INN: TEV-48574 Other descriptive name: ...	Teva Branded Pharmaceutical Products R&D, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	280	Phase 2	United States;Czechia;Slovakia;Spain;Austria;Israel;United Kingdom;Italy;France;Hungary;Czech Republ ...
4	EUCTR2021-002537-41-FR (EUCTR)	20/12/2022	03/01/2023	Safety and Efficacy of Efavaleukin Alfa in Subjects with Moderately to Severely Active Ulcerative Co ...	A Phase 2, Dose-finding, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate ...	Moderate to Severe Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 100 ...	Product Name: Efavaleukin Alfa Product Code: AMG 592 INN or Proposed INN: EFAVALEUKIN ALFA	Amgen Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	320	Phase 2	United States;Taiwan;Slovakia;Greece;Spain;Ukraine;Russian Federation;Switzerland;Italy;France;Denma ...
5	EUCTR2021-005528-39-NL (EUCTR)	14/12/2022	12/09/2022	Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Modera ...	A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Stud ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: JNJ-78934804 INN or Proposed INN: Guselkumab Other descriptive name: Guselkumab INN or Pr ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	550	Phase 2	Portugal;Taiwan;Hong Kong;Slovakia;Greece;Ukraine;Chile;Italy;India;France;Jordan;Denmark;Latvia;Kor ...
6	EUCTR2021-002549-13-PT (EUCTR)	02/08/2022	27/10/2021	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	Serbia;United States;Portugal;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy ...
7	EUCTR2021-002308-11-ES (EUCTR)	21/07/2022	21/07/2022	A phase 2/3, multicenter, randomized, double-blind study to evaluate the efficacy, safety, pharmacok ...	A phase 2/3, multicenter, randomized, double-blind study to evaluate the efficacy, safety, pharmacok ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: Ozanimod HCL Product Code: RPC1063 INN or Proposed INN: Ozanimod HCL Other descriptive na ...	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 2;Phase 3	France;United States;Canada;Belgium;Poland;Spain;Russian Federation;Israel;Germany;Netherlands;Unite ...
8	EUCTR2021-005288-31-PL (EUCTR)	04/07/2022	19/05/2022	A Phase 2a study to evaluate the Efficacy, Safety, and Tolerability of MORF-057 in Ulcerative Coliti ...	A Phase 2a, Open-label, Single-arm Study to Evaluate the Efficacy, Safety, and Tolerability of MORF- ...	Moderate to Severe Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;T ...	Product Name: MORF-057 Product Code: MORF-057 INN or Proposed INN: MORF-057 Other descriptive name: MOR ...	Morphic Therapeutic, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	35	Phase 2	United States;Poland
9	EUCTR2020-004457-76-HU (EUCTR)	17/05/2022	10/03/2022	A Long-term Extension Study of Ustekinumab in Pediatric Participants with different medical conditio ...	A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Cl ...	Paediatric conditions in - Moderately to Severely Active Crohn's Disease - Moderately to Severely Ac ...	Trade Name: STELARA® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab O ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	151	Phase 3	United States;Spain;Turkey;Russian Federation;Italy;United Kingdom;France;Hungary;Argentina;Belgium; ...
10	EUCTR2021-003702-42-ES (EUCTR)	17/05/2022	12/05/2022	A Phase 3 Placebo-controlled Efficacy and Safety Study with Ritlecitinib (PF-06651600) in Adults wit ...	AN INTERVENTIONAL PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY OF THE ...	Moderate to Severe Ulcerative Colitis (UC) MedDRA version: 20.1;Level: LLT;Classification code 10045 ...	Product Name: Ritlecitinib Product Code: PF-06651600 INN or Proposed INN: PF-06651600 Other descriptive ...	Pfizer Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	432	Phase 3	Serbia;United States;Taiwan;Slovakia;Greece;Spain;Ukraine;Russian Federation;Israel;Switzerland;Ital ...

First Previous1 2 3 4 5…163Next Last